Benchtop Bioreactors

Benchtop Bioreactors Market Outlook

The global benchtop bioreactors market is projected to reach a valuation of approximately USD 3.5 billion by the year 2035, at a compound annual growth rate (CAGR) of around 12.7% during the forecast period from 2025 to 2035. This significant growth is driven by the increasing demand for biopharmaceuticals, along with advancements in biotechnology and life sciences research. The rising prevalence of chronic diseases, the growing focus on personalized medicine, and the expansion of biomanufacturing capabilities are expected to further propel market growth. Moreover, the growing awareness of sustainable practices in various industries, such as food and beverage, agriculture, and environmental biotechnology, is significantly enhancing the adoption of benchtop bioreactors. The ability of these systems to provide controlled environments for cell growth and production processes makes them an essential component across multiple applications.

Growth Factor of the Market

The benchtop bioreactors market is primarily influenced by several key growth factors. Firstly, the rapid advancements in bioprocessing technologies have enabled the development of more efficient and versatile bioreactor systems that cater to a wide range of applications. As research institutions and pharmaceutical companies continue to embrace bioprocess optimization, there is a rising need for benchtop systems that facilitate small-scale experimentation and production. Secondly, the increasing investment in biotechnology research and development has created a conducive environment for innovation in bioreactor technologies. Furthermore, the growing trend towards automation in laboratories and manufacturing facilities has prompted the integration of sophisticated control systems and monitoring solutions in benchtop bioreactors, enhancing their efficiency and reliability. Additionally, the rising prevalence of infectious diseases and the subsequent demand for vaccine development have necessitated the use of bioreactors for accelerated production processes. Lastly, the increasing focus on environmentally friendly production methods in agriculture and food industries is expected to further boost the demand for benchtop bioreactors.

Key Highlights of the Market

• Projected market size of approximately USD 3.5 billion by 2035.
• Expected CAGR of around 12.7% during the forecast period from 2025 to 2035.
• High demand for biopharmaceuticals driving market growth.
• Significant advancements in bioprocessing technologies enhancing efficiency.
• Rising focus on sustainable and environmentally friendly production practices.

By Product Type

Stirred Tank Bioreactors:

Stirred tank bioreactors stand as one of the most conventional and widely utilized platforms in bioprocessing. These systems are characterized by their ability to maintain uniform mixing and optimal aeration, which is crucial for the growth of microbial and mammalian cells. The design of stirred tank bioreactors allows for the effective transfer of oxygen, nutrients, and other essential components, thereby supporting various biological reactions. Additionally, the scalability of stirred tank systems makes them suitable for both laboratory-scale experiments and large-scale production processes. With the continual advancements in bioreactor design, innovations such as the incorporation of advanced sensors and control systems are enhancing the performance and monitoring of stirred tank bioreactors, thereby driving their market growth significantly.

Single-Use Bioreactors:

Single-use bioreactors have gained considerable traction in the benchtop bioreactor market due to their advantages in terms of ease of use, reduced contamination risk, and lower operational costs. These systems are pre-sterilized and designed for single-use, eliminating the need for cleaning and sterilization between batches, which can be time-consuming and costly. The flexibility of single-use bioreactors allows for rapid scaling and adaptation to different production needs, making them particularly appealing to small and medium enterprises (SMEs) and startups in the biotechnology sector. The rising trend of personalized medicine and the need for agile manufacturing processes have further propelled the adoption of single-use bioreactors across various applications, including biopharmaceutical production and research.

Wave-Induced Bioreactors:

Wave-induced bioreactors represent a novel approach to bioprocessing, utilizing wave motion to achieve mixing and nutrient distribution within the culture medium. This unique mechanism enhances cell growth and productivity, making them an attractive option for specific applications where shear-sensitive cell lines are used. The gentle mixing action reduces the risk of cell damage and promotes a more stable growth environment. Moreover, wave-induced bioreactors are designed to be compact and modular, allowing for easy integration into existing laboratory setups. The growing acceptance of wave-induced bioreactors in research laboratories and pilot plants is contributing to the overall expansion of the benchtop bioreactors market.

Bubble Column Bioreactors:

Bubble column bioreactors are known for their simplicity and effectiveness in aerating liquid cultures. These systems operate by introducing air or gas bubbles at the bottom of a vertical column, which rise through the liquid, creating a mixing effect that enhances mass transfer. The design allows for high cell density cultivation, making bubble column bioreactors suitable for applications in microbial fermentation and algal culture. Their relatively low capital and operational costs further contribute to their appeal in both research and industrial settings. The increasing focus on sustainable practices and biofuel production is likely to bolster the demand for bubble column bioreactors in the coming years.

Fluidized Bed Bioreactors:

Fluidized bed bioreactors offer a unique approach to bioprocessing by utilizing a bed of solid particles that is kept in a fluidized state through the upward flow of liquid. This technology enhances mass transfer and provides a high surface area for microbial attachment, leading to increased productivity. Fluidized bed bioreactors are particularly advantageous in applications involving immobilized cell systems, where cell retention is essential for continuous production processes. Their versatility and efficiency in various bioprocessing applications have made fluidized bed bioreactors a significant segment within the benchtop bioreactor market, especially in the context of wastewater treatment and bio-remediation efforts.

By Application

Research and Development:

Research and development (R&D) activities constitute a critical segment within the benchtop bioreactor market. The versatility of benchtop bioreactors renders them ideal for conducting experiments in cell culture, fermentation, and process optimization. With researchers increasingly seeking to explore new bioprocess strategies and improve yields, the demand for advanced bioreactor systems is surging. Furthermore, the growing collaboration between academic institutions and industry players is likely to enhance R&D initiatives, fostering innovation in bioprocessing technologies. As R&D efforts continue to expand, the benchtop bioreactor market is expected to benefit significantly from increased investments and technological advancements.

Biopharmaceutical Manufacturing:

Biopharmaceutical manufacturing is a key driver of the benchtop bioreactor market, as these systems play a pivotal role in the production of therapeutic proteins, antibodies, and vaccines. The rising demand for biologics, coupled with the need for efficient production systems, has led biopharmaceutical companies to invest in benchtop bioreactors for process development and optimization. The ability of these systems to provide controlled environments for cell growth allows for the development of high-quality biopharmaceutical products. Additionally, the increasing prevalence of chronic diseases and the growing focus on personalized medicine are expected to further stimulate the demand for benchtop bioreactors in this application segment.

Food and Beverage Industry:

The food and beverage industry is increasingly adopting bioreactor technologies for the fermentation of various products, including alcoholic beverages, dairy products, and probiotics. Benchtop bioreactors enable manufacturers to experiment with different fermentation conditions, ensuring consistent quality and flavor profiles in their products. The growing consumer demand for organic and health-promoting food products is driving innovation in fermentation processes, thereby boosting the adoption of benchtop bioreactors. As food and beverage manufacturers continue to explore new fermentation techniques and product formulations, the benchtop bioreactor market is poised for steady growth within this application segment.

Environmental Biotechnology:

Environmental biotechnology is emerging as a vital application area for benchtop bioreactors, particularly in the context of wastewater treatment and bioremediation efforts. These systems are utilized to optimize microbial processes that degrade pollutants and improve water quality. The increasing emphasis on sustainable practices and regulatory pressures to minimize environmental impacts are driving the adoption of bioreactor technologies in this field. As researchers and environmental agencies seek efficient solutions for pollution control and ecosystem restoration, benchtop bioreactors are becoming essential tools in the advancement of environmental biotechnology.

Agriculture:

In agriculture, benchtop bioreactors are gaining traction for their application in the production of biofertilizers, biopesticides, and other microbial products that enhance soil health and crop yield. These systems provide controlled environments for the growth of beneficial microorganisms that can be used to improve agricultural productivity sustainably. The increasing awareness of the adverse effects of chemical fertilizers and pesticides is driving the demand for biotechnological alternatives, consequently propelling the benchtop bioreactor market. As the agriculture sector continues to embrace sustainable practices, the role of benchtop bioreactors in developing eco-friendly agricultural solutions is likely to expand significantly.

By Distribution Channel

Direct Sales:

Direct sales constitute a crucial distribution channel in the benchtop bioreactors market, wherein manufacturers sell their products directly to end-users. This approach allows companies to maintain better control over pricing, customer relations, and overall sales strategies. Direct sales enable manufacturers to provide personalized service to their clients, including tailored solutions and technical support that cater to specific research or production needs. As the demand for customized bioprocessing solutions continues to rise, the significance of direct sales as a distribution mechanism is expected to grow, facilitating more streamlined interactions between manufacturers and consumers.

Distributor Sales:

Distributor sales represent an important channel in the benchtop bioreactor market, enabling manufacturers to extend their reach through established networks of distributors and resellers. This distribution model allows companies to tap into a wider customer base, particularly in regions where they may not have direct presence or operational capabilities. Distributors offer valuable insights into local market trends and customer preferences, which can be leveraged by manufacturers to refine their product offerings. The growth of the biotechnology sector and the expanding applications of benchtop bioreactors are likely to enhance the role of distributor sales in the overall market landscape.

By Material

Glass Bioreactors:

Glass bioreactors are widely utilized in laboratory settings due to their transparent nature, allowing for easy monitoring of the culture process. The inert properties of glass make it suitable for a variety of biological applications, as it does not interact with the culture medium or affect cell growth. These bioreactors are particularly favored for small-scale experiments, where visual observation and sampling ease are paramount. However, glass bioreactors may have limitations in scale-up processes, often requiring additional handling and care. Despite these challenges, their widespread use in research laboratories ensures a consistent demand for glass bioreactors within the benchtop market.

Stainless Steel Bioreactors:

Stainless steel bioreactors are known for their durability, strength, and ability to withstand high-temperature sterilization processes. These bioreactors are often employed in larger-scale production facilities, thanks to their robustness and longevity. The design of stainless steel bioreactors allows for effective cleaning and reuse, making them a cost-efficient option for long-term operations. Their applications span across various industries, including pharmaceuticals and food processing, where reliability and compliance with stringent hygiene standards are critical. The growth in biopharmaceutical manufacturing is likely to sustain the demand for stainless steel bioreactors over the forecast period.

Single-Use Bioreactors:

Single-use bioreactors are becoming increasingly popular due to their convenience and efficiency in bioprocessing applications. These bioreactors eliminate the need for complex cleaning and sterilization procedures, significantly reducing turnaround times between batches. The pre-sterilized nature of single-use systems minimizes contamination risks, making them particularly suitable for sensitive applications, including the manufacture of biologics and vaccines. The flexibility and scalability of single-use bioreactors make them an essential choice for many biotechnology companies, especially those focused on agile manufacturing and rapid product development. As more organizations seek to optimize their biomanufacturing processes, the adoption of single-use bioreactors is expected to grow substantially.

Other Materials:

In addition to glass, stainless steel, and single-use materials, other innovative materials are being explored for bioreactor construction. This includes advanced polymers and composites that offer unique benefits, such as enhanced biocompatibility, lightweight design, and improved thermal insulation. These alternative materials can address specific challenges faced in bioprocessing, such as reducing weight for mobile applications or enhancing resistance to chemical corrosion. As research into new materials continues to evolve, the segment of bioreactors constructed from other materials is anticipated to expand, catering to niche applications where traditional materials may fall short.

By Region

The North America region holds a significant share of the benchtop bioreactors market, driven by the presence of advanced biotechnology companies, research institutions, and a strong focus on pharmaceutical innovation. The growing investment in R&D activities, coupled with an increasing emphasis on drug development and personalized medicine, is projected to propel market growth in this region. North America is expected to witness a CAGR of approximately 13.5% during the forecast period, reinforcing its position as a key market for benchtop bioreactor systems. The region's commitment to advancing bioprocessing technologies is further supported by government initiatives and funding programs aimed at fostering innovation in the biotechnology sector.

In Europe, the benchtop bioreactors market is also experiencing robust growth, led by escalating demand for biopharmaceuticals and increased focus on sustainable food production practices. European countries, particularly Germany, France, and the United Kingdom, are at the forefront of biotechnological research and development. The region's stringent regulatory framework surrounding biopharmaceutical manufacturing is driving manufacturers to invest in advanced bioreactor systems that adhere to compliance standards. The European market is projected to grow steadily, with a CAGR of around 11.2%, as companies seek to optimize their production processes and improve overall efficiency.

Opportunities

The benchtop bioreactors market presents numerous opportunities for growth and innovation, particularly as the biotechnology landscape continues to evolve. One significant opportunity lies in the increasing collaboration between academic institutions and industry players, which can lead to the co-development of cutting-edge bioreactor technologies. These collaborations often foster innovation, as researchers can access the latest advancements in bioprocessing while manufacturers gain insights into emerging trends and scientific discoveries. Moreover, the shift towards personalized medicine and targeted therapies is creating a demand for more adaptable and customizable bioreactor systems, offering manufacturers the chance to develop solutions that cater to specific research needs. As the biotechnology field embraces new methodologies, the potential for growth in the benchtop bioreactors market becomes even more pronounced.

Another opportunity for the benchtop bioreactors market lies in the expansion of applications beyond pharmaceuticals and food production. Industries such as environmental biotechnology and agriculture are increasingly recognizing the benefits of bioprocessing technologies, driving demand for benchtop systems tailored to these sectors. The growing awareness of sustainability and eco-friendly practices is prompting companies to adopt biotechnological solutions that minimize environmental impacts. By capitalizing on these trends and diversifying their product offerings, manufacturers can tap into new market segments and drive further growth. Expanding into emerging markets, where biotechnology is gaining traction, also presents a lucrative opportunity for companies seeking to enhance their global presence.

Threats

Despite the promising growth trajectory of the benchtop bioreactors market, there are inherent threats that could impede progress and development. One major threat is the rapid pace of technological advancements, which poses a challenge for manufacturers to keep up with evolving consumer demands and preferences. As new bioprocessing technologies emerge, companies may find it increasingly difficult to maintain a competitive edge if they cannot innovate quickly enough. Furthermore, the high costs associated with research and development activities can strain budgets, particularly for smaller firms operating in the biotechnology sector. If companies are unable to allocate sufficient resources to R&D, they risk falling behind in terms of product offerings and technological capabilities.

Additionally, regulatory challenges represent a significant threat to the benchtop bioreactors market. The stringent regulations governing biopharmaceutical manufacturing and bioprocessing can create hurdles for companies seeking to bring new products to market. Compliance with these regulations often requires extensive documentation and validation processes, leading to increased time and investment. Companies that fail to navigate the regulatory landscape effectively may face delays in product launches or even penalties, which can negatively impact their market positioning. As the industry continues to evolve, it is crucial for manufacturers to stay informed about regulatory changes and ensure compliance to mitigate these potential threats.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• GE Healthcare
• Merck KGaA
• Eppendorf AG
• Sartorius AG
• ABEC Inc.
• Finesse Solutions, Inc.
• PBS Biotech, Inc.
• Biotech Support Group LLC
• Parker Hannifin Corporation
• Avantor, Inc.
• Corning Incorporated
• Azbil Corporation
• Repligen Corporation
• Kuhner Shaker AG

The competitive landscape of the benchtop bioreactors market is characterized by a diverse range of companies, each vying for market share through innovation, product differentiation, and strategic partnerships. Major players in this market are leveraging advancements in technology to develop state-of-the-art bioreactor systems that meet the evolving needs of researchers and manufacturers. Companies such as Thermo Fisher Scientific and GE Healthcare are at the forefront, offering a comprehensive portfolio of bioprocessing solutions that include benchtop bioreactors, monitoring systems, and associated bioprocessing equipment. These industry leaders are also investing heavily in R&D efforts to drive innovation and enhance their product offerings, ensuring they remain competitive in this rapidly evolving market.

Merck KGaA and Sartorius AG are also key competitors in the benchtop bioreactor space, focusing on providing integrated solutions that optimize bioprocessing workflows. Their dedication to sustainability and efficiency in biomanufacturing processes positions them as trusted partners for biotechnology companies looking to enhance production capabilities. Additionally, emerging players like PBS Biotech and Finesse Solutions are gaining traction by introducing innovative and flexible bioreactor technologies that cater to niche applications in research and development. The dynamic nature of the market encourages companies to explore novel approaches to design and functionality, fostering a competitive environment that drives growth and innovation.

In summary, the benchtop bioreactors market is characterized by a mix of established and emerging players, all contributing to the advancement of bioprocessing technologies. Companies such as Eppendorf AG and Corning Incorporated are positioning themselves as leaders in the market by offering high-quality, reliable bioreactor systems that meet strict regulatory standards. As the market continues to expand, the competitive landscape is likely to intensify, leading to further innovations and enhancements in benchtop bioreactor technology. The ability of companies to adapt to market trends and anticipate customer needs will ultimately determine their success in this dynamic environment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ABEC Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Sartorius AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Avantor, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 GE Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Kuhner Shaker AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Azbil Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 PBS Biotech, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Corning Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Repligen Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Finesse Solutions, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Biotech Support Group LLC
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Parker Hannifin Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Benchtop Bioreactors Market, By Material
    • 6.1.1 Glass Bioreactors
    • 6.1.2 Stainless Steel Bioreactors
    • 6.1.3 Single-Use Bioreactors
    • 6.1.4 Other Materials
  • 6.2 Benchtop Bioreactors Market, By Application
    • 6.2.1 Research and Development
    • 6.2.2 Biopharmaceutical Manufacturing
    • 6.2.3 Food and Beverage Industry
    • 6.2.4 Environmental Biotechnology
    • 6.2.5 Agriculture
  • 6.3 Benchtop Bioreactors Market, By Product Type
    • 6.3.1 Stirred Tank Bioreactors
    • 6.3.2 Single-Use Bioreactors
    • 6.3.3 Wave-Induced Bioreactors
    • 6.3.4 Bubble Column Bioreactors
    • 6.3.5 Fluidized Bed Bioreactors
  • 6.4 Benchtop Bioreactors Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Benchtop Bioreactors Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Benchtop Bioreactors market is categorized based on

By Product Type

• Stirred Tank Bioreactors
• Single-Use Bioreactors
• Wave-Induced Bioreactors
• Bubble Column Bioreactors
• Fluidized Bed Bioreactors

By Application

• Research and Development
• Biopharmaceutical Manufacturing
• Food and Beverage Industry
• Environmental Biotechnology
• Agriculture

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material

• Glass Bioreactors
• Stainless Steel Bioreactors
• Single-Use Bioreactors
• Other Materials

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• GE Healthcare
• Merck KGaA
• Eppendorf AG
• Sartorius AG
• ABEC Inc.
• Finesse Solutions, Inc.
• PBS Biotech, Inc.
• Biotech Support Group LLC
• Parker Hannifin Corporation
• Avantor, Inc.
• Corning Incorporated
• Azbil Corporation
• Repligen Corporation
• Kuhner Shaker AG